FDA approves first cell therapy for wrinkle-free visage.
0/5 보강
APA
Schmidt C (2011). FDA approves first cell therapy for wrinkle-free visage.. Nature biotechnology, 29(8), 674-5. https://doi.org/10.1038/nbt0811-674
MLA
Schmidt C. "FDA approves first cell therapy for wrinkle-free visage.." Nature biotechnology, vol. 29, no. 8, 2011, pp. 674-5.
PMID
21822225 ↗
추출된 의학 개체 (NER)
해부
cell
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | cell
|
scispacy | 1 | ||
| 약물 | FDA approves
|
scispacy | 1 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
- Individualized lesion-oriented test-bolus arterial-phase CT improves lesion enhancement and conspicuity in hepatocellular carcinoma.
- to: "Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance".
- Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Impact of prior endoscopic or surgical interventions on clinical outcomes after peroral endoscopic myotomy for achalasia.
- Photoacoustic imaging at the interface of cellular theranostics.
- Comprehensive treatment for intracranial invasive sinonasal intestinal-type adenocarcinoma with a focus on radiotherapy dosage and immunological combination therapy: A case report.
- Efficacy and Safety of Intratympanic Botulinum Toxin Injection on Middle Ear Myoclonic Tinnitus.
- Anticholinergic Burden and Botulinum Toxin Needs after Deep Brain Stimulation in Adult and Pediatric Patients with Dystonia.
- Optimal target localization for botulinum toxin A in treating splenius muscles dystonia based on the distribution of intramuscular nerves and spindles.